|
|
||||||||
J Thorac Cardiovasc Surg 2007;133:1122-1123
© 2007 The American Association for Thoracic Surgery
Letter to the Editor |
The Université René Descartes, AP-HP, Service de Chirurgie Cardio-Vasculaire, Hôpital Européen Georges Pompidou, Paris, France
| The first 20% of the full text of this article appears below. |
To the Editor:
We read with great interest the case report of Kohout and colleagues1
describing the successful management of acute necrotizing eosinophilic myocarditis (ANEM) with a biventricular assist device (BIVAD) and steroids.
ANEM is indeed a dramatic condition often leading to a fatal issue unless promptly managed with circulatory support and steroid administration.2
Endomyocardial biopsy is essential to diagnosis confirmation and rapid therapeutic choice making.
The particularity of ANEM is rapid and spectacular circulatory improvement when steroids are administered early enough.2
Therefore, we think that a BIVAD is probably too aggressive and that a far less-invasive mean, such as extracorporeal life support (ECLS), is
Related Article
J. Thorac. Cardiovasc. Surg. 2007 133: 1123-1124.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |